Biote (BTMD) vs Ispire Technology (ISPR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Ispire Technology (ISPR) has outperformed Biote (BTMD) over the past year, losing 39.0% versus a loss of 60.9%. Ispire Technology is the larger company by market cap ($81.4 million vs $37.6 million), about 2.2 times the size. On valuation, Biote trades at a lower forward P/E (2.5x vs 70.5x for Ispire Technology).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BTMD | ISPR |
|---|---|---|
| Share price | $1.11 | $1.41 |
| Market cap | $37.63M | $81.43M |
| 1-day change | -2.63% | +6.02% |
| YTD return | -57.31% | -49.64% |
| 1-year return | -60.92% | -38.96% |
| 5-year return | -88.64% | — |
| P/E ratio (TTM) | 7.93 | — |
| Forward P/E | 2.47 | 70.50 |
| EPS (TTM) | $0.14 | $-0.58 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.26 | $3.87 |
| 52-week low | $1.09 | $1.01 |
| Distance from 52-week high | -65.95% | -63.57% |
| Average volume | 230.83K | 35.70K |
| Shares outstanding | 28.68M | 57.75M |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Ispire Technology is about 2.2 times larger than Biote by market value ($81.43M vs $37.63M).
- ISPR has outperformed BTMD by 22.0 percentage points over the past year.
BTMD vs ISPR FAQ
Which is bigger, Biote or Ispire Technology?
Ispire Technology (ISPR) is larger, with a market capitalization of $81.43M compared with $37.63M for Biote (BTMD).
Which stock has performed better over the past year, BTMD or ISPR?
ISPR returned -38.96% over the past 12 months, compared with -60.92% for BTMD (price return, excluding dividends). Past performance does not predict future results.
Are Biote and Ispire Technology in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.